CTLT vs LUNG
CTLT (CTLT) versus Pulmonx Corp (LUNG) — a side-by-side from cached financials, not a winner call.
CTLT (CTLT) common stock.
Pulmonx Corp (LUNG) is a medical devices company listed on US.
CTLT does not have a complete income-statement cache yet.
Latest reported LUNG revenue for 2024-12-31 was $83.8M. Net income was -$56.4M. Revenue was up 22.0% from 2023-12-31 to 2024-12-31. LUNG currently screens at market cap $111.9M.
LUNG currently screens at market cap $111.9M.
Not investment advice. Open the CTLT and LUNG stock pages for the full models.
Not investment advice.